| Course | NUR 540 Advanced Pathophysiology Across the Life Span |
|---|---|
| Module | Module 4 |
| Paper type | Case-based pathophysiology short paper |
| Length | About 1,150 words, 7 pages |
| Format | APA 7 student paper |
| School | Southern New Hampshire University |
| Program | MSN |
| Updated | September 2026 |
Free sample paper for NUR 540 Module 4
When Compensation Becomes Disease: A 74-Year-Old's Heart Failure With Reduced Ejection Fraction
[Student Name]
Southern New Hampshire University
NUR 540: Advanced Pathophysiology Across the Life Span
Short Paper
[Instructor Name]
[Date]
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
When Compensation Becomes Disease: A 74-Year-Old's Heart Failure With Reduced Ejection Fraction
Heart failure with reduced ejection fraction begins with an injured heart, but much of what makes patients sick comes from the body's attempt to help. Nerves and hormones that evolved to defend blood pressure after hemorrhage are switched on by a failing pump and stay on, and over months they enlarge, stiffen and scar the heart they were meant to support (Hartupee & Mann, 2016). This paper explains that process in a composite 74-year-old admitted with decompensated heart failure. It argues that the patient's congestion, low sodium and worsening heart function all follow from sustained neurohormonal activation, and that each class of guideline-directed medical therapy works by blocking a specific part of that response.
The Case
A 74-year-old with a large anterior myocardial infarction two years earlier, hypertension and type 2 diabetes arrived by ambulance after a week of worsening breathlessness. The patient now slept on three pillows, woke gasping at night and had gained 3 kg. The patient was breathing 24 times a minute, saturating 90% on room air, with a pulse of 104 and a pressure of 138/86 mm Hg. The jugular venous pressure was raised, crackles were heard at both lung bases, a third heart sound was present and pitting edema reached both knees. B-type natriuretic peptide (BNP) was 1,450 pg/mL, sodium 132 mmol/L, and creatinine had climbed to 1.7 mg/dL from the 1.2 recorded at the last clinic visit. On echocardiography the left ventricle was enlarged, its anterior wall no longer moved and it ejected only 30% of its volume with each beat.
The Original Injury
The infarction destroyed a large section of the anterior left ventricle. Dead myocytes were replaced by scar, which cannot contract, so the ventricle lost part of its pumping muscle. With less muscle able to shorten, each beat empties less of the chamber's volume, and stroke volume falls. On the Frank-Starling curve, a weakened ventricle sits on a flatter curve: increases in filling produce only small increases in output, so the heart can no longer respond to more volume by pumping more (Rogers, 2023). This is systolic dysfunction, and an ejection fraction of 30% places the patient firmly in the reduced ejection fraction category.
The Neurohormonal Response
A falling stroke volume is sensed by stretch-sensitive pressure receptors in the neck's carotid arteries and in the arch of the aorta, and by the kidneys as reduced perfusion. Three systems respond.
Sympathetic outflow speeds and strengthens each beat while tightening arterioles and veins. In the short term this maintains blood pressure; the patient's heart rate of 104 is its visible sign. Over time, sustained catecholamine exposure is toxic to myocytes, promotes arrhythmias and down-regulates beta receptors.
The renin-angiotensin-aldosterone system is activated by sympathetic stimulation of the kidney and by reduced renal perfusion. Angiotensin II constricts vessels, raising afterload against a weak ventricle, and stimulates aldosterone release. Aldosterone causes the kidney to retain sodium and water and, acting on the heart, promotes fibrosis. Angiotensin II also stimulates thirst and vasopressin release.
Vasopressin (antidiuretic hormone) opens water channels in the kidney's collecting ducts, so more free water returns to the blood. Because it retains water more than sodium, it dilutes the blood, which explains the sodium of 132 mmol/L; hyponatremia in heart failure is a marker of intense neurohormonal activation (Hartupee & Mann, 2016).
One counter-regulatory system pushes the other way. Stretch of the ventricular walls releases natriuretic peptides, which promote sodium excretion and vasodilation. The BNP of 1,450 pg/mL reflects the degree of wall stress, but in advanced heart failure the natriuretic response is overwhelmed by the systems opposing it.
Remodeling and Congestion
Sustained activation of these systems remodels the ventricle. Myocytes lengthen and the chamber dilates, the wall thins relative to the cavity, fibrosis stiffens the tissue and the ventricle becomes more spherical. A larger, rounder chamber has higher wall stress for any given pressure, which worsens function and further stimulates the neurohormonal systems, a self-reinforcing cycle (Hartupee & Mann, 2016).
Congestion is the product of this cycle. Retained sodium and water expand blood volume, raising filling pressures. Pressure transmitted back to the pulmonary veins pushes fluid into the lung interstitium and alveoli, producing crackles, hypoxemia and breathlessness that worsens lying flat, when fluid redistributes from the legs to the chest. Raised right-sided pressures distend the jugular veins and drive fluid into the tissues of the legs. The third heart sound reflects rapid filling into a dilated, noncompliant ventricle. The rise in creatinine reflects reduced renal perfusion and venous congestion of the kidney.
How Therapy Targets the Mechanism
The 2022 heart failure guideline recommends four classes of medication for patients with reduced ejection fraction, and each blocks a link in the chain described above (Heidenreich et al., 2022). Table 1 summarizes them.
Table 1
Guideline Therapies for HFrEF and the Mechanisms They Target
| Drug class | Mechanism it targets | Effect on the process |
|---|---|---|
| Angiotensin receptor-neprilysin inhibitor (or ACE inhibitor or ARB) | Angiotensin II; breakdown of natriuretic peptides | Less vasoconstriction and aldosterone; more natriuresis; slows remodeling |
| Evidence-based beta-blocker | Sustained sympathetic stimulation | Slower heart rate; less myocyte toxicity and arrhythmia; reverse remodeling over months |
| Mineralocorticoid receptor antagonist | Aldosterone | Less sodium retention and myocardial fibrosis |
| SGLT2 inhibitor | Sodium and glucose reabsorption; other cardiac and renal effects | Natriuresis and diuresis; reduced hospitalization and death |
| Loop diuretic | Retained sodium and water | Relieves congestion; does not alter remodeling |
The distinction in the last row matters. A loop diuretic relieves this patient's congestion quickly, but only the four disease-modifying classes act on the neurohormonal drivers of remodeling. Neprilysin inhibition also has a practical consequence: because neprilysin breaks down BNP, BNP rises on treatment, so NT-proBNP is the better marker for monitoring a patient taking sacubitril-valsartan.
Age and This Patient
Age changes the heart and the response to therapy. The aging heart is stiffer, with more fibrosis and reduced responsiveness to beta-adrenergic stimulation, so older adults have less reserve to raise output during stress. Heart failure with preserved ejection fraction becomes more common with age, which makes the echocardiogram essential to classify this patient's failure correctly. Older adults are more likely to have reduced kidney function, which complicates the use of aldosterone antagonists and raises the risk of high potassium, and to experience orthostatic hypotension when several blood-pressure-lowering drugs are started together. For this patient, guideline therapy is still indicated, but it should be introduced and adjusted step by step with close monitoring of blood pressure, potassium and creatinine (Heidenreich et al., 2022).
Conclusion
A heart attack removed a large part of this patient's pumping muscle. The sympathetic nervous system, the renin-angiotensin-aldosterone system and vasopressin responded as they would to blood loss, preserving pressure at the cost of retained fluid, vasoconstriction, low sodium and a remodeled, failing ventricle. The patient's breathlessness, edema and rising BNP are the visible results. Guideline therapy works because it blocks those same responses, and in an older adult it must be introduced with attention to the kidneys and blood pressure.
References
Hartupee, J., & Mann, D. L. (2016). Neurohormonal activation in heart failure with reduced ejection fraction. Nature Reviews Cardiology, 14(1), 30-38. https://doi.org/10.1038/nrcardio.2016.163
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., Fang, J. C., Fedson, S. E., Fonarow, G. C., Hayek, S. S., Hernandez, A. F., Khazanie, P., Kittleson, M. M., Lee, C. S., Link, M. S., . . . Yancy, C. W. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145(18), e895-e1032. https://doi.org/10.1161/CIR.0000000000001063
Rogers, J. L. (Ed.). (2023). McCance & Huether's pathophysiology: The biologic basis for disease in adults and children (9th ed.). Elsevier.
What the NUR 540 Module 4 instructions ask for
The cardiovascular module in NUR 540 usually presents a patient with a cardiac or vascular condition, often heart failure, coronary disease or hypertension, and asks you to explain its pathophysiology. Typical requirements are describing the initial injury or abnormality, the compensatory mechanisms and how they become harmful, the relationship between the mechanisms and the patient's signs, symptoms, diagnostics and lab values, the rationale for treatment and the effects of age. Papers commonly run two to four pages in APA 7 with current sources, and a current guideline is expected when you discuss treatment. Draw the chain of cause and effect for yourself before writing, from the first injury to each symptom, and keep it beside you as you draft.
How this NUR 540 Module 4 short paper example is built
In this sample, a composite 74-year-old develops decompensated heart failure two years after a large anterior infarction. The paper explains the original injury and the flattened Frank-Starling curve, then describes the sympathetic, renin-angiotensin-aldosterone and vasopressin responses, each with its short-term benefit, long-term harm and link to a finding such as tachycardia or low sodium. Natriuretic peptides are explained as the losing counterweight. Remodeling is shown as a cycle, and every congestive sign is accounted for. A table maps each guideline drug class to the mechanism it blocks, and the age section covers stiffness, classification and safe titration. Three real sources support it: a pathophysiology text, a review of neurohormonal activation and the current guideline.
Where the NUR 540 Module 4 rubric puts the points
Cardiovascular papers are generally graded on accurate description of the primary pathology, depth in explaining compensation and decompensation, correlation with the case findings, treatment rationale grounded in mechanism and current guidance, life span considerations and writing. Compensation is the section where depth shows most clearly; naming the renin-angiotensin-aldosterone system is not enough without explaining how it retains sodium, raises afterload and promotes fibrosis. Correlation earns full credit when every abnormal finding in the case is explained. Treatment should reflect the current guideline, and papers that omit newer drug classes, or treat diuretics as disease-modifying, lose accuracy points. Citing the guideline year makes it easy for the grader to see your recommendations are current.
NUR 540 Module 4 help: the mistakes that cost points
Heart failure papers often go wrong by listing symptoms by side of the heart without linking them to the neurohormonal story, by describing compensation as purely helpful or by using outdated treatment recommendations. Another common gap is leaving lab values such as sodium or natriuretic peptide unexplained. Trace the chain from injury through each compensatory system to each finding, show where compensation turns harmful, map treatments to mechanisms and address age specifically. Use the latest guideline for any drug recommendation, and name its year in the text. If your case involves a different cardiovascular condition, we can prepare a short paper that explains it from mechanism to treatment.
Get NUR 540 Module 4 written to your instructions
Send the case, the module prompt and the rubric. A cardiovascular pathophysiology paper that traces compensation, explains every finding and maps treatment to mechanism is ready in 24 to 48 hours, and the first one is free. The paper above is an original model document written by our desk, not a submitted student paper and not an official Southern New Hampshire University document.
More NUR 540 papers and related MSN samples
- NUR 540 Module 1 Short Paper: Cellular Injury After an Acetaminophen Overdose
- NUR 540 Module 2 Short Paper: Anaphylaxis in a School-Age Child
- NUR 540 Module 3 Final Project Milestone One: The Pathophysiology of Pneumonia Progressing to Sepsis in an Older Adult
- NUR 540 Module 5 Short Paper: An Asthma Exacerbation in a School-Age Child
- NUR 540 Module 6 Short Paper: Minimal Change Nephrotic Syndrome in a Toddler
- NUR 540 Module 7 Final Project Milestone Two: Clinical Decision Making, Technology and Treatment in Sepsis
- NUR 540 Module 8 Short Paper: Diabetic Ketoacidosis in a Teenager With New Type 1 Diabetes
- NUR 540 Module 9 Final Project: A Complete Case Study of Pneumococcal Sepsis in an Older Adult
- NUR 540 Module 10 Journal: Thinking About Disease Across the Life Span
- NUR 506 Module 7 Implementation Plan Paper
- NUR 531 Module 5 Root Cause Analysis Paper: A Root Cause Analysis of a Healthcare-Associated Legionnaires' Case
- NUR 520 Module 9 Final Project: An Epidemiological Analysis of COPD With Population-Level Recommendations
- NUR 530 Module 5 Project One: A Systems Analysis of Discharge Delays on a Medical Unit
NUR 540 Module 4 questions, answered
Where can I find a free NUR 540 Module 4 Short Paper sample?
The complete paper on this page is free to read: a composite 74-year-old's HFrEF, explained from infarction to neurohormonal activation, remodeling, congestion, therapy and age effects.
Why does neurohormonal activation worsen heart failure?
Sympathetic, angiotensin and aldosterone activity retain fluid, raise afterload and promote fibrosis and myocyte injury, which remodels the ventricle and further reduces its function.
Why is sodium low in heart failure?
Vasopressin release causes the kidneys to retain water more than sodium, diluting the blood. Low sodium signals strong neurohormonal activation.
What are the main drug classes for HFrEF?
Current guidelines recommend an angiotensin receptor-neprilysin inhibitor or alternative, an evidence-based beta-blocker, a mineralocorticoid receptor antagonist and an SGLT2 inhibitor, with diuretics for congestion.
How does age affect heart failure?
The aging heart is stiffer and less responsive to adrenergic stimulation, preserved ejection fraction becomes more common, and kidney function and blood pressure limit how fast therapy can be added.